PL2804863T3 - Nowe postacie i sole inhibitora syntazy aldosteronowej lub aromatazy dihydropirolo[1,2-c]imidazolilu - Google Patents

Nowe postacie i sole inhibitora syntazy aldosteronowej lub aromatazy dihydropirolo[1,2-c]imidazolilu

Info

Publication number
PL2804863T3
PL2804863T3 PL13701194T PL13701194T PL2804863T3 PL 2804863 T3 PL2804863 T3 PL 2804863T3 PL 13701194 T PL13701194 T PL 13701194T PL 13701194 T PL13701194 T PL 13701194T PL 2804863 T3 PL2804863 T3 PL 2804863T3
Authority
PL
Poland
Prior art keywords
dihydropyrrolo
imidazolyl
salts
new forms
aromatase inhibitor
Prior art date
Application number
PL13701194T
Other languages
English (en)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2804863(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2804863T3 publication Critical patent/PL2804863T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL13701194T 2012-01-17 2013-01-15 Nowe postacie i sole inhibitora syntazy aldosteronowej lub aromatazy dihydropirolo[1,2-c]imidazolilu PL2804863T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor
EP13701194.6A EP2804863B1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number Publication Date
PL2804863T3 true PL2804863T3 (pl) 2016-06-30

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13701194T PL2804863T3 (pl) 2012-01-17 2013-01-15 Nowe postacie i sole inhibitora syntazy aldosteronowej lub aromatazy dihydropirolo[1,2-c]imidazolilu

Country Status (40)

Country Link
US (2) US9334276B2 (pl)
EP (1) EP2804863B1 (pl)
JP (1) JP5749410B2 (pl)
KR (2) KR20140093726A (pl)
CN (1) CN104039793B (pl)
AP (1) AP2014007762A0 (pl)
AR (1) AR089728A1 (pl)
AU (1) AU2013209952B2 (pl)
BR (1) BR112014017260A8 (pl)
CA (1) CA2863339C (pl)
CL (1) CL2014001863A1 (pl)
CO (1) CO7000775A2 (pl)
CR (1) CR20140345A (pl)
CU (1) CU20140086A7 (pl)
CY (1) CY1117914T1 (pl)
DK (1) DK2804863T3 (pl)
EA (1) EA026232B1 (pl)
ES (1) ES2564143T3 (pl)
GT (1) GT201400155A (pl)
HR (1) HRP20160178T1 (pl)
HU (1) HUE026984T2 (pl)
IL (1) IL233541B (pl)
IN (1) IN2014DN06781A (pl)
JO (1) JO3137B1 (pl)
MA (1) MA35858B1 (pl)
MX (1) MX2014008686A (pl)
NZ (1) NZ626277A (pl)
PE (1) PE20142358A1 (pl)
PH (1) PH12014501638A1 (pl)
PL (1) PL2804863T3 (pl)
RS (1) RS54589B1 (pl)
SG (1) SG11201404061YA (pl)
SI (1) SI2804863T1 (pl)
SM (1) SMT201600083B (pl)
TN (1) TN2014000256A1 (pl)
TW (1) TWI609869B (pl)
UA (1) UA114803C2 (pl)
UY (1) UY34576A (pl)
WO (1) WO2013109514A1 (pl)
ZA (1) ZA201404314B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA33904B1 (fr) * 2010-01-14 2013-01-02 Novartis Ag Utilisation d'un agent de modification d'hormones surrénaliennes
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
TWI707682B (zh) 2014-07-07 2020-10-21 瑞士商瑞科戴迪股份有限公司 醫藥劑型
AU2016210899B2 (en) 2015-01-29 2019-03-07 Recordati Ag Process for the production of condensed imidazolo Derivatives
WO2016164476A2 (en) * 2015-04-06 2016-10-13 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
JP7130636B2 (ja) * 2016-10-27 2022-09-05 ダミアン ファーマ アーゲー アルドステロンシンターゼ阻害剤
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
SG11202010906XA (en) 2018-05-03 2020-12-30 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
JPH07503242A (ja) 1992-01-27 1995-04-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アロマターゼ阻害剤としてのピロロイミダゾリルおよびイミダゾピリジニル置換１ｈ−ベンズイミダゾール誘導体
PT1565463E (pt) * 2002-11-18 2008-09-10 Novartis Ag Derivados de imidazo[1,5-a]piridina e métodos para tratar doenças mediadas pela aldosterona
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
MX2009006481A (es) 2006-12-18 2009-06-26 Novartis Ag Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona.
CN102666535B (zh) 2009-11-30 2015-02-25 诺华股份有限公司 作为醛固酮合酶抑制剂的咪唑衍生物
MA33904B1 (fr) * 2010-01-14 2013-01-02 Novartis Ag Utilisation d'un agent de modification d'hormones surrénaliennes

Also Published As

Publication number Publication date
AU2013209952B2 (en) 2016-09-01
PH12014501638B1 (en) 2014-10-13
EA201491374A1 (ru) 2014-12-30
CL2014001863A1 (es) 2014-11-07
CY1117914T1 (el) 2017-05-17
IL233541A0 (en) 2014-08-31
CU20140086A7 (es) 2014-12-26
RS54589B1 (sr) 2016-08-31
UA114803C2 (uk) 2017-08-10
US20140364470A1 (en) 2014-12-11
ES2564143T3 (es) 2016-03-18
WO2013109514A1 (en) 2013-07-25
CN104039793A (zh) 2014-09-10
CN104039793B (zh) 2017-05-10
NZ626277A (en) 2015-10-30
TN2014000256A1 (en) 2015-09-30
SG11201404061YA (en) 2014-08-28
SI2804863T1 (sl) 2016-05-31
TW201335161A (zh) 2013-09-01
ZA201404314B (en) 2015-08-26
CO7000775A2 (es) 2014-07-21
IL233541B (en) 2018-12-31
HK1198536A1 (en) 2015-05-15
HUE026984T2 (en) 2016-08-29
ES2564143T8 (es) 2020-11-18
EP2804863A1 (en) 2014-11-26
PH12014501638A1 (en) 2014-10-13
UY34576A (es) 2013-09-02
BR112014017260A8 (pt) 2017-07-04
JP2015503627A (ja) 2015-02-02
KR20140093726A (ko) 2014-07-28
JP5749410B2 (ja) 2015-07-15
TWI609869B (zh) 2018-01-01
SMT201600083B (it) 2016-04-29
PE20142358A1 (es) 2015-01-30
US20160176883A1 (en) 2016-06-23
CA2863339C (en) 2021-03-23
GT201400155A (es) 2017-09-28
BR112014017260A2 (pt) 2017-06-13
MA35858B1 (fr) 2014-12-01
JO3137B1 (ar) 2017-09-20
US9334276B2 (en) 2016-05-10
EA026232B1 (ru) 2017-03-31
KR20140141687A (ko) 2014-12-10
CA2863339A1 (en) 2013-07-25
CR20140345A (es) 2014-09-09
AU2013209952A1 (en) 2014-07-24
HRP20160178T1 (hr) 2016-03-25
EP2804863B1 (en) 2015-12-02
MX2014008686A (es) 2014-08-27
AP2014007762A0 (en) 2014-07-31
AR089728A1 (es) 2014-09-10
IN2014DN06781A (pl) 2015-05-22
DK2804863T3 (en) 2016-03-07

Similar Documents

Publication Publication Date Title
IL233541B (en) Salts and forms of dihydropyrrolo[1,2-c] imidazole aldosterone synthase or aromatase inhibitor
GB2498145B (en) Releasable corrosion inhibitors
EP2552208A4 (en) IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
ZA201308198B (en) Combinations of akt inhibitor compounds and abiraterone, and methods of use
IL221823A (en) Pipridine-4-Il-Aztidine Derivatives as Jack 1 Suppressors
EP2552214A4 (en) PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
EP2552211A4 (en) INDAZOLYL-PYRIMIDINE AS KINASEHEMMER
IL221311A0 (en) Inhibitors of protein kinases
GB201009731D0 (en) Kinase inhibitors
GB201016880D0 (en) Phosphodiesterase inhibitors
ZA201206456B (en) Uses of dgati inhibitors
IL225605A0 (en) Polo-like kinase inhibitors
SG11201404654SA (en) Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
ZA201300036B (en) Banzamide derivatives and their use as hsp90 inhibitors
ZA201208895B (en) Bicyclic compound derivatives and their use as acc inhibitors
GB201020798D0 (en) Corrosion inhibitors
GB201219678D0 (en) Ketone body inhibitors and uses thereof
IL222379A0 (en) Kras primers and probes
PL2646448T3 (pl) Makrocykliczne inhibitory kinazy
PL2721009T3 (pl) Pochodne pirazolu użyteczne jako inhibitory syntazy aldosteronu
GB201003949D0 (en) Inhibitors of protein kinases
GB201018597D0 (en) Inhibitors
GB201010218D0 (en) Corrosion inhibitor